"RNA Editing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE).
| Descriptor ID |
D017393
|
| MeSH Number(s) |
G02.111.760.250 G03.839.250 G05.308.700.250
|
| Concept/Terms |
RNA Editing- RNA Editing
- Editing, RNA
- Editings, RNA
- RNA Editings
- RNA, Messenger, Editing
|
Below are MeSH descriptors whose meaning is more general than "RNA Editing".
Below are MeSH descriptors whose meaning is more specific than "RNA Editing".
This graph shows the total number of publications written about "RNA Editing" by people in this website by year, and whether "RNA Editing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 3 | 1 | 4 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 1 | 3 |
| 2021 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "RNA Editing" by people in Profiles.
-
Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems. Viruses. 2021 07 15; 13(7).
-
AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19. Front Immunol. 2021; 12:690416.
-
From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution. Cells. 2021 06 20; 10(6).
-
Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA. PLoS Pathog. 2021 06; 17(6):e1009596.
-
IFN-a levels in ruxolitinib-treatead Aicardi-Goutières patient during SARS-CoV-2 infection: A case report. Clin Immunol. 2021 06; 227:108743.
-
Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease. J Immunol. 2021 04 15; 206(8):1691-1696.
-
The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection. Clin Immunol. 2021 05; 226:108699.
-
RNA editors: key regulators of viral response in cancer patients. Epigenomics. 2021 02; 13(3):165-167.
-
Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution. Virology. 2021 04; 556:62-72.
-
[APOBEC3s: history of an antiviral and mutagenic protein family]. Virologie (Montrouge). 2020 12 01; 24(6):381-418.